Clinical Trial Update: Behavioral and Pharmacological Reconsolidation Interference in Misophonia [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial investigating behavioral and pharmacological reconsolidation interference for misophonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Misophonia

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Misophonia | EARLY_Phase 1 | Status: COMPLETED